Treatment of Mycoplasma genitalium infection: efficacy of a resistance-guided strategy using doxycycline-moxifloxacin or doxycycline-azithromycin.
Resistance-guided antimicrobial therapy using doxycycline-moxifloxacin and doxycycline-2.5g azithromycin for the treatment of Mycoplasma genitalium infection: efficacy and tolerability.
Rédigé par : Dr Jean-Pierre Bru
Macrolide-resistance in Mycoplasma genitalium (MG) exceeds 50% in many regions and quinolone-resistance is increasing. The aim of the study was to determine the microbial cure rates with two different regimen chosen by resistance guided strategy : doxycycline-azithromycin and doxycycline-moxifloxacin.
Methods
Patients attending an Australian Sexual Health Centre between 201...
Ce contenu est à destination des professionnels de santé. Merci de vous identifier.
This content is intended for healthcare professionals. Thank you for identifying yourself.
This content is intended for healthcare professionals. Thank you for identifying yourself.
Déjà inscrit / Already registered ?
Créer un compte / Create an account
Créer un compte ne prend que quelques minutes et vous permettra d'accèder à l'ensemble des contenus du site.
Creating an account takes only instant and will allow you to access all the content of the website.